Form 4: Amir Cohen Reports Strata Critical Medical Stock Activity

Chief Accounting Officer Amir Cohen acquired and disposed of shares of Strata Critical Medical, Inc. following the vesting of performance-based restricted stock units.

Summary

• Amir Cohen, Chief Accounting Officer of Strata Critical Medical, Inc., acquired 83,505 shares of Class A common stock on April 23, 2026, upon the certification of performance criteria for previously granted PSUs.
• On April 24, 2026, 40,960 shares were withheld by the company to satisfy tax obligations related to the vesting of these units.
• Following these transactions, the reporting person holds a total of 216,444 shares of Class A common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard executive compensation vesting rather than a change in strategic direction or market sentiment.

Positives

• The acquisition of 83,505 shares reflects the successful achievement of performance-based criteria established by the Compensation Committee.

Negatives

• The transaction involved a mandatory withholding of 40,960 shares to cover tax liabilities, reducing the net increase in the reporting person's holdings.

Risks

• The value of the shares is subject to market volatility, as evidenced by the $4.92 per share valuation used for tax withholding purposes.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that this filing is a routine disclosure of executive compensation and equity vesting, which is standard practice for publicly traded companies to maintain transparency regarding insider ownership.

Comparison to Industry Standards

• The use of performance-based restricted stock units (PSUs) is a standard industry practice for aligning executive incentives with company performance goals.
• The withholding of shares to cover tax obligations is a common administrative procedure for equity-based compensation plans.

Stakeholder Impact

• The transaction confirms the achievement of performance targets, which may be viewed positively by shareholders as an indicator of management meeting established goals.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Strata Critical Medical, SRTA, Form 4, Insider Trading, Performance-based Restricted Stock Units, Chief Accounting Officer